- Home
- TSI vs SRTS Comparison
TSI vs SRTS Comparison
Compare TSI & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSI
- SRTS
- Stock Information
- Founded
- TSI 1987
- SRTS 2010
- Country
- TSI United States
- SRTS United States
- Employees
- TSI N/A
- SRTS N/A
- Industry
- TSI Investment Managers
- SRTS Medical/Dental Instruments
- Sector
- TSI Finance
- SRTS Health Care
- Exchange
- TSI Nasdaq
- SRTS Nasdaq
- Market Cap
- TSI 234.6M
- SRTS 83.9M
- IPO Year
- TSI N/A
- SRTS 2016
- Fundamental
- Price
- TSI $4.91
- SRTS $4.67
- Analyst Decision
- TSI
- SRTS Strong Buy
- Analyst Count
- TSI 0
- SRTS 3
- Target Price
- TSI N/A
- SRTS $11.67
- AVG Volume (30 Days)
- TSI 106.8K
- SRTS 56.4K
- Earning Date
- TSI 01-01-0001
- SRTS 08-07-2025
- Dividend Yield
- TSI 7.46%
- SRTS N/A
- EPS Growth
- TSI N/A
- SRTS N/A
- EPS
- TSI N/A
- SRTS 0.11
- Revenue
- TSI N/A
- SRTS $39,488,000.00
- Revenue This Year
- TSI N/A
- SRTS $4.33
- Revenue Next Year
- TSI N/A
- SRTS $31.55
- P/E Ratio
- TSI N/A
- SRTS $42.60
- Revenue Growth
- TSI N/A
- SRTS 24.75
- 52 Week Low
- TSI $4.48
- SRTS $4.01
- 52 Week High
- TSI $4.87
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- TSI 47.93
- SRTS 47.56
- Support Level
- TSI $4.87
- SRTS $4.50
- Resistance Level
- TSI $4.99
- SRTS $4.99
- Average True Range (ATR)
- TSI 0.05
- SRTS 0.20
- MACD
- TSI -0.00
- SRTS -0.02
- Stochastic Oscillator
- TSI 55.26
- SRTS 33.54
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.